Publications by authors named "Maximiliano Cassilha Kneubil"

Literature shows that HER2/neu positive breast cancer cells are more sensitive to radiation-induced apoptosis by targeting the epidermal growth factor receptor family tyrosine kinase. We selected 466 patients with pT1-2 HER2/neu positive tumors who received adjuvant trastuzumab for primary invasive breast cancer. Patients were divided into three groups [Quadrantectomy followed by conventional radiotherapy vs Quadrantectomy followed by Intra-operative radiotherapy with electrons vs Mastectomy without radiotherapy].

View Article and Find Full Text PDF

Background: The selections of nipple-sparing mastectomy (NSM) are principally depending on oncologic indication and oncologic safety. The main complication of NSM is nipple areolar complex (NAC) necrosis, and it is usually related to surgical technique. However, the patients' clinicopathological factors should be also considered.

View Article and Find Full Text PDF

Background: Our purpose was to evaluate the locoregional recurrence (LRR) of patients with false-negative, frozen-section or close margins of retroareolar specimen in nipple-sparing mastectomy (NSM) procedure.

Methods: From 2002-2008, we recruited patients who had atypia or presence of cancer cells in definitive histology of retroareolar tissue despite of absence of tumor cell in intraoperative retroareolar frozen section. We also included the close margin cases defined as the presence of tumor cells at the first frozen section, but after deeper core out of retroareolar tissue were revealed free of malignancy.

View Article and Find Full Text PDF
Article Synopsis
  • Trastuzumab combined with chemotherapy is the recommended treatment for HER2 positive breast cancer, but there is limited research on its effects in elderly patients.
  • A systematic review indicated a significant 47% reduction in risk for those over 60 receiving trastuzumab compared to chemotherapy alone, while cardiac events were relatively low at 5%.
  • Despite the effectiveness of trastuzumab in this age group, it's important to assess individual health factors and address ongoing concerns about cardiac safety during treatment.
View Article and Find Full Text PDF